Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-23

Clinical Trial Update: Resync-AF (Rate vs Rhythm Control in AF Patients With CRT-D) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update comparing rate versus rhythm control in atrial fibrillation patients with CRT-D has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Pittsburgh | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED